Prelude Capital Management’s Intuitive Surgical ISRG Stock Holding History

Prelude Capital Management’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,700	Closed	-$716K	–	1320
2022 Q4	$716K	Buy	+2,700	New	+$658K	0.04%	454
2022 Q3	–	Sell	-3,600	Closed	-$723K	–	1744
2022 Q2	$723K	Sell	3,600 -900	-20%	-$211K	0.02%	646
2022 Q1	$1.36M	Buy	4,500 +3,000	+200%	+$876K	0.04%	479
2021 Q4	$539K	Buy	+1,500	New	+$516K	0.01%	960
2016 Q2	–	Sell	-3,600	Closed	-$240K	–	1646
2016 Q1	$240K	Buy	+3,600	New	+$223K	0.03%	490
2014 Q2	–	Sell	-41,400	Closed	-$2.02M	–	2044
2014 Q1	$2.02M	Buy	+41,400	New	+$1.95M	0.27%	63

Other funds holding ISRG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prelude Capital Management's ISRG Position: Q1 2026 in Review

Prelude Capital Management increased its Intuitive Surgical (ISRG) stake by 75% in Q1 2026, buying an estimated $578K and bringing the position to 2,661 shares worth $1.23M. The position accounts for 0.09% of the portfolio, ranked #254.

Prelude Capital Management first reported a position in ISRG in Q3 2013 and has held it in 35 quarters since. The position peaked at $1.99M in Q1 2022. 2,305 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

Prelude Capital Management held 2,661 shares of Intuitive Surgical worth $1.23M as of Q1 2026.
Prelude Capital Management bought 1,142 Intuitive Surgical shares in Q1 2026, an estimated $578K.
Intuitive Surgical made up 0.09% of Prelude Capital Management's portfolio in Q1 2026, its #254 holding.
Prelude Capital Management first reported a position in Intuitive Surgical in Q3 2013 and has held it in 35 quarters since.
Prelude Capital Management's Intuitive Surgical position peaked at $1.99M in Q1 2022.
2,305 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.